Sg Americas Securities, LLC United Therapeutics Corp Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 1,493 shares of UTHR stock, worth $550,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,493
Previous 899 66.07%
Holding current value
$550,603
Previous $286,000 87.06%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$311.04 - $363.55 $184,757 - $215,948
594 Added 66.07%
1,493 $535,000
Q2 2024

Jul 12, 2024
SELL
$228.26 - $319.04 $3.06 Million - $4.28 Million
-13,416 Reduced 93.72%
899 $286,000
Q1 2024

May 06, 2024
BUY
$210.76 - $249.51 $1.92 Million - $2.28 Million
9,133 Added 176.24%
14,315 $3.29 Million
Q4 2023

Jan 12, 2024
SELL
$214.88 - $256.94 $1.83 Million - $2.19 Million
-8,516 Reduced 62.17%
5,182 $1.14 Million
Q3 2023

Oct 13, 2023
BUY
$211.82 - $248.24 $2.9 Million - $3.4 Million
13,698 New
13,698 $3.09 Million
Q1 2023

Apr 28, 2023
SELL
$212.99 - $276.17 $1.88 Million - $2.44 Million
-8,826 Reduced 59.88%
5,914 $1.32 Million
Q4 2022

Feb 02, 2023
BUY
$205.95 - $280.43 $3.04 Million - $4.13 Million
14,740 New
14,740 $4.1 Million
Q2 2022

Jul 29, 2022
BUY
$174.81 - $241.14 $842,933 - $1.16 Million
4,822 Added 114.59%
9,030 $2.13 Million
Q1 2022

Apr 29, 2022
SELL
$166.16 - $213.96 $1.14 Million - $1.46 Million
-6,833 Reduced 61.89%
4,208 $755,000
Q4 2021

Feb 07, 2022
BUY
$184.32 - $216.08 $494,161 - $579,310
2,681 Added 32.07%
11,041 $2.39 Million
Q3 2021

Nov 01, 2021
BUY
$179.86 - $214.88 $600,732 - $717,699
3,340 Added 66.53%
8,360 $1.54 Million
Q2 2021

Aug 12, 2021
SELL
$170.47 - $211.93 $762,000 - $947,327
-4,470 Reduced 47.1%
5,020 $901,000
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $242,609 - $275,563
1,576 Added 19.91%
9,490 $1.59 Million
Q4 2020

Feb 04, 2021
SELL
$101.87 - $151.79 $1.35 Million - $2.01 Million
-13,261 Reduced 62.63%
7,914 $1.2 Million
Q3 2020

Nov 09, 2020
BUY
$99.9 - $121.13 $960,338 - $1.16 Million
9,613 Added 83.14%
21,175 $2.14 Million
Q2 2020

Jul 20, 2020
BUY
$92.74 - $125.82 $441,720 - $599,280
4,763 Added 70.05%
11,562 $1.4 Million
Q1 2020

Apr 30, 2020
SELL
$79.39 - $115.35 $500,950 - $727,858
-6,310 Reduced 48.13%
6,799 $645,000
Q4 2019

Jan 28, 2020
SELL
$78.31 - $95.34 $378,628 - $460,968
-4,835 Reduced 26.94%
13,109 $1.16 Million
Q3 2019

Nov 04, 2019
SELL
$74.85 - $85.99 $112,274 - $128,984
-1,500 Reduced 7.71%
17,944 $1.43 Million
Q2 2019

Jul 29, 2019
BUY
$76.06 - $120.81 $772,237 - $1.23 Million
10,153 Added 109.28%
19,444 $1.52 Million
Q1 2019

Apr 29, 2019
SELL
$107.15 - $126.84 $11,357 - $13,445
-106 Reduced 1.13%
9,291 $1.09 Million
Q4 2018

Feb 01, 2019
SELL
$101.4 - $128.73 $330,969 - $420,174
-3,264 Reduced 25.78%
9,397 $1.02 Million
Q3 2018

Nov 06, 2018
BUY
$113.81 - $129.46 $352,014 - $400,419
3,093 Added 32.33%
12,661 $1.62 Million
Q2 2018

Aug 07, 2018
BUY
$101.14 - $118.31 $146,653 - $171,549
1,450 Added 17.86%
9,568 $1.08 Million
Q1 2018

May 03, 2018
SELL
$107.21 - $151.94 $209,917 - $297,498
-1,958 Reduced 19.43%
8,118 $912,000
Q4 2017

Jan 24, 2018
SELL
$118.58 - $151.28 $85,733 - $109,375
-723 Reduced 6.7%
10,076 $1.49 Million
Q3 2017

Nov 07, 2017
BUY
$114.6 - $136.81 $1.24 Million - $1.48 Million
10,799
10,799 $1.27 Million

Others Institutions Holding UTHR

# of Institutions
672
Shares Held
42.4M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email